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Abstract
In this paper, a deterministic model involving the transmission dynamics of malaria/visceral
leishmaniasis co-infection is presented and studied. Optimal control theory is then applied
to investigate the optimal strategies for curtailing the spread of the diseases using the use of
personal protection, indoor residual spraying and culling of infected reservoirs as the system
control variables. Various combination strategies were examined so as to investigate the
impact of the controls on the spread of the disease. And we investigated the most cost-effec-
tive strategy of all the control strategies using three approaches, the infection averted ratio
(IAR), the average cost-effectiveness ratio (ACER) and incremental cost-effectiveness ratio
(ICER). Our results show that the implementation of the strategy combining all the time
dependent control variables is the most cost-effective control strategy. This result is further
emphasized by using the results obtained from the cost objective functional, the ACER, and
the ICER.
1 Introduction
Malaria and visceral leishmaniasis (VL) are two major parasitic diseases with overlapping dis-
tributions which are both epidemiological and geographical in nature. This overlap may conse-
quently lead to co-infection of the two parasites in the same patients [1]. Due to this co-
infection, these parasites may partially share the same host tissues, with the ability to evade and
subvert the host immune response; the clinical outcomes, however, depend largely on the
immunological status of the host [1]. Furthermore, the success of the visceral Leishmania
donovani complex obligate intracellular parasites in colonizing the macrophages and other
reticulo-endothelial cells of the lymphoid system is due to their ability to alter the host’s para-
site destruction signaling pathways and adaptive immunity engagement [2].
Visceral leishmaniasis patients who live in unstable seasonal malaria areas, such as eastern
Sudan are exposed to the risk of co-infection [3]; however due to the variation in the geograph-
ical distribution of these co-infection cases, there might be some environmental and/or social
factors associated with these risks of malaria-visceral leishmaniasis co-infections [3]. The prev-
alence of these co-infections in many VL’s endemic foci ranges from 31% in Sudan, 20% in
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Uganda and 1.2% in Bangladesh [3]. Concomitant malaria infections in unstable seasonal
malaria areas are able to exacerbate VL symptoms in co-infected patients without affecting
their prognosis if adequate and effective malaria treatment are provided; however, co-infected
patients may experienced increase risks in mortality due to anti-malarial treatment failure to
drugs such as chloroquine, sulfadoxine-pyrimethamine (SP) and quinine [3]. Hence, it is
imperative for health officials in these VL foci with unstable malaria to ensure systematic
malaria screening for all VL patients and artemisinin-based combination therapies (ACTs)
treatment for patients with malaria [3].
Post-kala-azar dermal leishmaniasis (PKDL) occurs as a consequence of VL; it is caused by
leishmania donovani in infected patients who have been cured of VL 6 months to 1 or more
years prior to its appearance [4, 5]. It is common in VL endemic areas such as Sudan, Bangla-
desh, and India. PKDL may occur in endemic areas with L. infantum or L. chagasi, places such
as the Mediterranean countries and Latin America [6]. Leishmania donovani in most cases is
not a zoonotic parasite unlike L. infantum; however, there have been documentation of
infected dogs in places with L. donovani. For instance Mo’awia et al. [7] showed that phleboto-
mus orientalis (VL main vector) in Sudan prefer dogs to other mammals like the Egyptian
mongoose, common genet and Nile rat. Furthermore, domestic dogs might be the most
important reservoir of L. donovani in eastern Africa [8, 9]. A study of VL risk factor in Ethiopia
showed that dogs tested positive for VL antibodies [10]. Also, strains of L. donovani have been
isolated from dogs in Kenya [11]. These studies iterates the possibilities of L. donovani being
zoonotic with dogs as the reservoir, particularly in places like Ethiopia, Sudan and Kenya.
It is important to note that our study is on the model of malaria-visceral leishmaniasis co-
infection, two infections that are endemic in Ethiopia, Sudan and Kenya. So without loss of
generality we use this model to gain insight into understanding the dynamics of the co-infec-
tion. Thus, we have not incorporated any regional or parasite species specific features and
parameters; these features will be incorporated as part of our future and further analysis. Thus,
in this paper we propose an optimal control model for the dynamics of malaria-visceral leish-
maniasis co-infection using the basic model of malaria-visceral leishmaniasis co-infection for-
mulated in [12]. The aim of this work is to find the optimal and most cost-effective strategy to
control both the mono-and co-infections in the community. This paper is organized as fol-
lows: in Section 2, we present the basic malaria-visceral leishmaniasis co-infection model and
its main properties. In Section 3, we carry out a sensitivity analysis to identify the model’s
parameters with the most impact on our response function. The optimal control problem is
stated in Section 4 with some numerical simulation exploration carried out in Section 5. The
cost-effectiveness analysis and discussions are given in Sections 6 and 7.
2 Malaria-visceral leishmaniasis co-infection model and its basic
properties
In this study, we consider the model without control proposed and analyzed by Elmojtaba
[12]. The model examined the dynamics of the malaria and visceral leishmaniasis co-infection
in four populations; human host population Nh(t), reservoir host population Nr(t), mosquito
population NvmðtÞ, and sandfly population NvlðtÞ. The human host population was divided
into eight categories, individuals susceptible to both malaria and visceral leishmaniasis Sh(t),
those who are infected with malaria only Ihmðt), those who are infected with visceral leishmani-
asis only IhlðtÞ, those who are infected with both malaria and visceral leishmaniasis IhmlðtÞ, The
population also include those who have developed post kala-azar dermal leishmaniasis
(PKDL) after the treatment of visceral leishmaniasis Ph(t), those who have developed PKDL
and have malaria PhmðtÞ, those who are recovered from leishmaniasis and have permanent
Malaria/visceral leishmaniasis co-infection
PLOS ONE | DOI:10.1371/journal.pone.0171102 February 6, 2017 2 / 31
immunity but susceptible to malaria Rh(t) and those who are recovered from leishmaniasis
and infected with malaria Rhm . Hence, the total human population is given as
NhðtÞ ¼ ShðtÞ þ IhmðtÞ þ IhlðtÞ þ IhmlðtÞ þ PhðtÞ þ PhmðtÞ þ RhðtÞ þ Rhm :ðtÞ
The reservoir host population is divided into two categories, susceptible reservoir Sr(t), and
infected reservoir Ir(t), such that the total population is
NrðtÞ ¼ SrðtÞ þ IrðtÞ:
The mosquito vector population is divided into two categories, susceptible mosquito vector
SvmðtÞ, and malaria parasite infected mosquito vector IvmðtÞ, such that
NvmðtÞ ¼ SvmðtÞ þ IvmðtÞ:
The sandfly population is similarly divided into two categories, susceptible sandflies SvlðtÞ,
and VL parasite infected sandflies IvlðtÞ. Hence, the total population is
NvlðtÞ ¼ SvlðtÞ þ IvlðtÞ:
It is assumed that susceptible humans are recruited into the population at a constant rate Γ.




, where am is the per capita biting rate of mosquitoes on humans, and bm is the
transmission probability of malaria per bite per human. Furthermore, humans acquire infec-




where al is the per capita biting rate of sandflies on humans (or reservoirs), and bl is the visceral
leishmaniasis transmission probability per bite per human. Humans infected with malaria
acquire infection with leishmaniasis following contacts with infected sandflies at the same per
capita rate as susceptible humans, die due to the disease at an average rate δ1 or recovered
without immunity and became susceptible again at an average rate γ1.
Visceral leishmaniasis infected humans acquire infection with malaria following contacts
with infected mosquitoes at the same per capita rate as susceptible humans, die due to leish-
maniasis at an average rate δ2, or get treatment at an average rate γ2. A fraction σ1 of those who
get treated recover and acquire permanent immunity, and the other fraction (1 − σ1) develop
PKDL. Dually infected humans either recover from malaria and became VL only infected or
get VL treatment and develop PKDL with malaria or recover from VL with malaria or die due
to the co-infection at an average rate δ3, with the assumption that dual infection reduces both
malaria recovery rate and VL treatment success.
Humans with PKDL only acquire infection with malaria following contacts with infected
mosquitoes at the same per capita rate as susceptible humans, get treated at an average rate γ3,
or recover naturally at an average rate β and acquire permanent immunity in both cases.
Humans with PKDL and malaria get either PKDL treatment at an average rate γ3, or recover
from PKDL naturally at an average rate β and acquire permanent immunity from VL in both
cases, or recover from malaria and still suffer from PKDL. Humans who recovered from VL
completely may acquire infection with malaria following contacts with infected mosquitoes at
the same per capita rate as susceptible humans, and humans who recovered from VL
completely and still suffer from malaria infection may recover from malaria infection at an
average rate γ1, but they will not acquire any new VL infection. There is a per capita natural
mortality rate μh in all human sub-population.
Susceptible reservoirs are recruited into the population at a constant rate Γr, and acquire
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and b as described above. We assume that the transmission probability per bite is the same for
human and reservoir because sandflies do not distinguish between humans and reservoirs. It is
also assumed that reservoirs disease induced death rate is negligible, but there is a per capita
natural mortality rate μr.
Susceptible mosquitoes are recruited at a constant rate Gvm , and acquire malaria infection
following contact with human infected with malaria, or humans dually infected, humans with
PKDL and malaria or humans who recovered from all VL forms and infected with malaria
with an average rate amcm
ðIhmþIhmlþPhmþRhm Þ
Nh
. Mosquitoes have a per capita natural mortality rate
mvm regardless of their infection status.
Susceptible sandflies are recruited at a constant rate Gvl , and acquire leishmaniasis infection
following contact with humans infected with leishmaniasis, humans dually infected, or human








, it is also assumed that sandflies have a per capita natural mortal-
ity rate mvl regardless of their infection status.
From the description above, we have the following system of differential equations repre-
senting the malaria-leishmaniasis co-infection:






þ g1Ihm   mhSh ð1Þ






  ðg1 þ d1 þ mhÞIhm
I 0hl ¼ alblIvl
Sh
Nh
þ 1g1Ihml   ambmIvm
Ihl
Nh
  ðg2 þ d2 þ mhÞIhl






  ðd3 þ 1g1 þ 2g2 þ mhÞIhml
P0h ¼ ð1   s1Þg2Ihl þ 3g1Phm   ambmIvm
Ph
Nh




þ ð1   s2Þ2g2Ihml   ð3g1 þ 4g3 þ 4bþ mhÞPhm







þ s22g2Ihml þ ð4g3 þ 4bÞPhm   ðg1 þ mhÞRhm
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S0vm ¼ Lvm   amcmSvm
ðIhm þ Ihml þ Phm þ RhmÞ
Nh
  mvmSvm
I 0vm ¼ amcmSvm
ðIhm þ Ihml þ Phm þ RhmÞ
Nh
  mvmIvm
S0vl ¼ Lvl   alclSvl







I 0vl ¼ alclSvl








N 0h ¼ Lh   mhNh   ðd1Ihm þ d2Ihl þ d3IhmlÞ
N 0r ¼ Lr   mrNr
N 0vm ¼ Lvm   mvmNvm
N 0vl ¼ Lvl   mvlNvl
The model variables and parameters are described in Tables 1 and 2.
Invariant region
All parameters of the model are assumed to be nonnegative, furthermore since model (1) mon-
itors living populations, it is assumed that all the state variables are nonnegative at time t = 0. It
is noted that in the absence of the diseases (δ1 = δ2 = δ3 = 0), the total human population size,
Nh! Λh/μh as t!1, also Nr! Λr/μr, Nvm ! Lvm=mvm and Nvl ! Lvl=mvl as as t!1. This
Table 1. Description of the state variables of the co-infection model (1).
Variable Description
Sh(t) Susceptible humans for both malaria and visceral leishmaniasis
IhmðtÞ Malaria only infected humans
Ihl ðtÞ Visceral leishmaniasis only infected humans
Ihml ðtÞ Co-infected humans
Ph(t) Humans who developed PKDL
Phm ðtÞ Humans who developed PKDL and infected with malaria
Rh(t) Humans who recovered from visceral leishmaniasis and susceptible to malaria
Rhm ðtÞ Humans who recovered from visceral leishmaniasis and infected with malaria
Sr(t) Susceptible reservoirs
Ir(t) Infected reservoirs
Svm ðtÞ Susceptible mosquitoes
Ivm ðtÞ Infected mosquitoes
Svl ðtÞ Susceptible sand flies
Ihl ðtÞ infected sand flies
doi:10.1371/journal.pone.0171102.t001
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shows that the biologically-feasible region:
O ¼ ðSh; Ihm ; Ihl ; Ihml ; Ph; Phm ;Rh;Rhm ; Sr; Ir; Svm ; Ivm ; Svl ; IvlÞ 2 R
14
þ
: Sh; Ihm ; Ihl ; Ihml ;
n













is positively-invariant domain, and thus, the model is epidemiologically and mathematically
well posed, and it is sufficient to consider the dynamics of the flow generated by Eq (1) in this
positively-invariant domain O.













R0 ¼ maxfRm ; Rlg, where Rm;Rl are the reproduction numbers of malaria and leishmania-
sis, respectively.
The following theorems summarize the important properties of the model (1), their proofs
are given in [12].
Theorem 2.1 The system (1) has four equilibrium points:
1. The disease-free equilibrium, which is locally asymptotically stable if R0 is less than unity, and
globally stable if the conditions of either Lemma 3.2 or Lemma 3.3 of [12] satisfied.
Table 2. Description of the parameters of the co-infection model (1).
Parameter Description
Λh Humans recruitment rate
Λr Reservoirs recruitment rate
Lvm Mosquitoes recruitment rate
Lvl Sandflies recruitment rate
μh Natural mortality rate of humans
μr Natural mortality rate of reservoirs
mvm Natural mortality rate of mosquitoes
mvl Natural mortality rate of sandflies
am Biting rate of mosquitoes
bm Progression rate of malaria in mosquito
cm Progression rate of malaria in human
al Biting rate of sandflies
bl Progression rate of VL in sandfly
cl Progression rate of VL in human and reservoir
u3 Rate of recovery after treatment from malaria by humans
u4 Treatment rate of VL
γ3 PKDL recovery rate after treatment
1 − σ1 Developing PKDL rate after treatment
1 − σ2 Developing PKDL rate after treatment in co-infected
δ1 Malaria induced death rate
δ2 VL induced death rate
δ3 Co-infection induced death rate
β PKDL recovery rate without treatment
1, 2, 3, 4 Modification parameters
doi:10.1371/journal.pone.0171102.t002
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2. The Visceral Leishmaniasis only endemic equilibrium, which is locally asymptotically stable if
Rl is greater than unity.
3. The Malaria only endemic equilibrium, which is locally asymptotically stable if Rm is greater
than unity.
4. The endemic equilibrium of coexistence, which exists if both Rl and Rm are greater than
unity.
Theorem 2.2 If the bifurcation quantity a is positive, then the system (1) undergoes a back-
ward bifurcation which occurs at R0 ¼ 1. (i.e.R0 < 1 is not sufficient for the eradication of the
diseases.)
3 Sensitivity analysis
Following [13, 14] we used the normalized forward sensitivity index also called elasticity, as it
is the backbone of nearly all other sensitivity analysis techniques [15] and are computationally
efficient [14]. The normalized forward sensitivity index of the quantity Q with respect to the










Using the elasticity formula (2) and the parameter sets in Table 3, we now obtain numerical
Table 3. Parameters values of the co-infection model (1).
Parameter Value References
Λh 0.0015875 × Nh [16]
Λr 0.0073 × Nr Assumed
Lvm 0:071 Nvm [16]














1 − σ1 0.36 [24]





1, 2, 3, 4 0.07, 0.04, 0.07, 0.01 Assumed
doi:10.1371/journal.pone.0171102.t003
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values for the elasticities. For each parameter θ we calculated the elasticity index of Rc
0
with
respect to θ. Results are displayed in Table 4
It is very clear from Table 4, am and al, the biting rate has the highest sensitivity index (s
index = 1), which indicates that any increase (decrease) by k% in am or al will be followed by
an immediate increase (decrease) by k% in R0. The immediate conclusion is that at the dis-
ease-free equilibrium the most effective control strategy is the vector control.
The second highest sensitivity index (s index = 0.5) is associated with bm, bl, cm and cl, the
progression rate of the malaria and leishmaniasis in hosts and vectors, respectively. These
parameters are out of control, therefore we can not use them as control parameters. Death rate
of vectors has a sensitivity index of −0.5 which suggests that any increase by k% in μvm or μvl
will be accompanied by a decrease of k
2
% in R0, and vice versa, which supports our claim that
vector control is the most effective control strategy. The sensitivity index of the treatment rate
of malaria is −0.49, which indicates that to reduce R0 we need to increase the treatment rate.
The death rate of the reservoir is also important in reducing R0 because it has sensitivity index
of −0.471. The sensitivity indexes for the other parameters are very small (−0.1–0.0001), which
indicate that they have no effect on R0. Therefore, in conclusion, the most effective control
strategy is a strategy that involves vector control either by reducing their biting rate or increas-
ing their death rate.
4 Optimal control problem
Following the conclusion obtained from the sensitivity analysis, we introduce into the malaria-
visceral leishmaniasis model (1) four time-dependent controls u1(t), u2(t), u3(t) and u4(t).
These time-dependent controls represent the use of personal protection measures (u1(t) and
u2(t)) such as the use of insecticide-treated nets, application of repellents or insecticides to skin
or to fabrics and impregnated animal collars (particularly dogs) [27] and the use of windows
and door screens to prevent both mosquitoes and sandflies bites both during the day and at
night. Furthermore, the time-dependent control u3(t) represents the culling of infected
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reservoir animals (like dogs) and the control u4(t) represents the use of insecticides such as
DDT, pyrethroids and residual spraying of dwellings and animal shelters [27] to kill the mos-
quitoes and sandflies. Thus, the malaria-visceral leishmaniasis model (1) with time-dependent
control is given as:




alblð1   u1ÞIvl Sh
Nh





alblð1   u1ÞIvl Ihm
Nh
  ðg1 þ d1 þ mhÞIhm
I 0hl ¼










alblð1   u1ÞIvl Ihm
Nh
  ðd3 þ 1g1 þ 2g2 þ mhÞIhml
P0h ¼ ð1   s1Þg2Ihl þ 3g1Phm  
ambmð1   u1ÞIvmPh
Nh




þ ð1   s2Þ2g2Ihml   ð3g1 þ 4g3 þ 4bþ mhÞPhm







þ s22g2Ihml þ ð4g3 þ 4bÞPhm   ðg1 þ mhÞRhm
S0r ¼ Lr  




alblð1   u2ÞIvl Sr
Nr
  mrIr   u3Ir
S0vm ¼ Lvm  
amcmð1   u1ÞðIhm þ Ihml þ Phm þ RhmÞSvm
Nh
  mvmSvm   u4Svm
I 0vm ¼
amcmð1   u1ÞðIhm þ Ihml þ Phm þ RMÞSvm
Nh
  mvmIvm   u4Ivm
S0vl ¼ Lvl   alclSvl






  mvl Svl   u4Svl
I 0vl ¼ alclSvl






  mvl Ivl   u4Ivl
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) that minimizes the cost objective
functional J(u1, u2, u3, u4) where
Jðu1; u2; u3; u4Þ ¼
Z tf
0









This performance specification involves the numbers of infected humans, reservoirs, mosqui-
toes and sandflies, along with the cost of applying the controls (u1(t), u2(t), u3(t) and u4(t)).
The coefficients, Ai, Cj, i = 1  8, j = 1  4, are balancing cost factors and tf is the final time.
The control quadruple (u1(t), u2(t), u3(t) and u4(t)) are bounded, Lebesgue integrable func-



















fJðu1; u2; u3; u4Þg ð5Þ
where the control set,
U ¼ fðu1ðtÞ; u2ðtÞ; u3ðtÞ; u4ðtÞÞ; ui: ½0; tf  ! ½0; 1; i ¼ 1;    4;
is Lebesgue measurableg;
Characterization of optimal controls
The necessary conditions that an optimal control quadruple must satisfy come from the Pon-
tryagin’s Maximum Principle [30]. This principle converts Eqs (3) and (4) into a problem of
minimizing pointwise a Hamiltonian H, with respect to the controls (u1, u2, u3, u4). First we
formulate the Hamiltonian from the cost functional Eq (4) and the governing dynamics Eq (3)
to obtain the optimality conditions.












where i = Sh, Ihm , Ihl , Ihml , Ph, Phm , Rh, Rhm , Sr, Ir, Svm , Ivm , Svl , Ivl and gi are the right-hand sides of
the system (3). Furthermore, lSh , lIhm
, lIhl
, lIhml
, λM, lPh , lPhm , lRh , lRhm , lSr , lIr , lSvm , lIvm , lSvl ,
lIvl
are the associated adjoints for the states Sh, Ihm , Ihl , Ihml , Ph, Phm , Rh, Rhm , Sr, Ir, Svm , Ivm , Svl , Ivl .
The system of adjoint equations is found by taking the appropriate partial derivatives of the
Hamiltonian Eq (6) with respect to the associated state and control variables.


























; Ivm ; S

vl





VÞ over U . Then there exists adjoint variables lSh , lIhm , lIhl , lIhml , λM, lPh ,
lPhm
, lRh , lRhm












and with transversality conditions
liðtf Þ ¼ 0; where i ¼ Sh; Ihm ; Ihl ; Ihml ; Ph; Phm ;Rh;Rhm ; Sr; Ir; Svm ; Ivm ; Svl ; Ivl : ð8Þ
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Þ are given as
u
1
¼ min 1;max 0;
1
2C1Nh
ðambmIvmShðlIhm   lShÞ þ alblIvlShðlIhl   lShÞ

þalblIvlIhmðlIhml   lIhmÞ þ ambmIvmIhlðlIhml   lIhlÞ þ ambmIvmRhðlRhm   lRhÞ
þambmIvmPhðlPhm   lPhÞ þ amcmðIhm þ Ihml þ Phm þ RhmÞSvmðlIvm   lSvmÞ






¼ min 1;max 0;
al
2C2
clSvlIrlIvl   blIvlSrlSr þ blIvlSrlIr   clSvlIrlSvl
Nr











¼ min 1;max 0;




Proof. The existence of an optimal control is guaranteed using the result by Fleming and
Rishel [31]. Thus, the differential equations governing the adjoint variables are obtained by the
differentiation of the Hamiltonian function, evaluated at the optimal controls. Thus, the



















































ðtf Þ ¼ 0;
evaluated at the optimal controls and corresponding state variables, results in the stated adjoint
systems (7) and (8). Furthermore, differentiating the Hamiltonian function with respect to the
Malaria/visceral leishmaniasis co-infection
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ðambmIvmShðlIhm   lShÞ þ alblIvlShðlIhl   lShÞ
þalblIvlIhmðlIhml   lIhmÞ þ ambmIvmIhlðlIhml   lIhlÞ þ ambmIvmRhðlRhm   lRhÞ
þambmIvmPhðlPhm   lPhÞ þ amcmðIhm þ Ihml þ Phm þ RhmÞSvmðlIvm   lSvmÞ



















IvllIvl þ SvmlSvm þ IvmlIvm þ SvllSvl
2C4
: ð12Þ
Using the bounds on the controls, the characterization Eq (9) can be derived.
Remark 1 Due to the a priori boundedness of the state and adjoint functions and the resulting
Lipschitz structure of the ODE’s, the uniqueness of the optimal control for small time (tf) was
obtained. The uniqueness of the optimal control quadruple follows from the uniqueness of the
optimality system, which consists of Eqs (3) and (7), Eq (8) with characterization Eq (9). The
restriction on the length of time interval is to guarantee the uniqueness of the optimality system,
the smallness in the length of time is due to the opposite time orientations of Eqs (3), (7) and (8);
the state problem has initial values and the adjoint problem has final values. This restriction is
very common in control problems (see [28, 32–37]).
Next we discuss the numerical solutions of the optimality system, the corresponding opti-
mal control and the interpretations from various cases.
5 Numerical illustrations
Numerical solutions to the optimality system comprising of the state eq (3), adjoint eq (7),
control characterizations Eq (8) and corresponding initial/final conditions are carried out
using the forward-backward sweep method (implemented in MATLAB) and using parameters
set in Table 3. The algorithm starts with an initial guess for the optimal controls and the state
variables are then solved forward in time using Runge Kutta method of the fourth order. Then
the state variables and initial control guess are used to solve the adjoint equations Eq (7) back-
ward in time with given final condition (8), employing the backward fourth order Runge
Kutta method. The controls u1(t), u2(t), u3(t), u4(t) are then updated and used to solve the state
and then the adjoint system. This iterative process terminates when the current state, adjoint,
and control values converge sufficiently [38].
In this section, we use numerical simulations to support the analytical results previously
established, and to provide examples about the dynamics of both diseases. We use the
Malaria/visceral leishmaniasis co-infection
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following initial conditions Nh = 500,000, Nr = 10,000, Nvm ¼ 30; 000 and Nvl ¼ 50; 000. Most
of the parameters used were found in the literature as seen in Table 3. However; some are
assumed such as reservoirs recruitment rate and the natural mortality rate of reservoirs which
is assumed because there are many potential reservoirs for leishmaniasis (see [39]). The rate at
which humans develop PKDL after treatment in co-infection cases is assumed because we
were unable to find any literature reference to it; therefore, we assume it is greater than the
rate in VL only humans.
The disease induced death rate in co-infected humans is also assumed due to lack of litera-
ture information on it. We similarly assumed it is greater than VL induced death rate in
humans who are infected with VL only. This assumption is made on the premise that there are
increased risks of mortality in co-infected patients, possibly due to inappropriate anti-malarial
treatment and treatment failure [1, 3]. Individuals in malaria endemic regions are known to
self-medicate on anti-malarial drugs [40–44]. For instance, in Ethiopia, Deressa et al. [42]
found that out of 616 households, 17.8% individuals self-mediate at home while 46.7% visit
health services after self-medicating at home. These individuals use mainly chloroquine and
sulfadoxine-pyrimethamine. Kimoloi et al. [43] found in a cross-sectional community based
study in Kenya, that 74% out of the 338 participants self-medicate on antimalarial drugs such
as sulphadoxine/sulphalene-pyrimethamine; majority (about 70.3%) self-medicated on Arte-
misinin-based combination therapies (ACT). Similarly in Sudan, Awad et al. [40] found 43.4%
of the 600 study households had self-medicated on antimalarials such as chloroquine and sul-
fadoxine-pyrimethamine.
Thus, to illustrate the effect of different optimal control strategies on the spread of disease
in a population, we will consider the following combination of time-dependent controls mak-
ing up four control strategies A-D:
Strategy A: combination of u1(t), u2(t), u3(t) and u4(t)
Strategy B: combination of u1(t), u2(t) and while setting u3(t) = u4(t) = 0;
Strategy C: combination of u3(t) and u4(t) while setting u1(t) = u2(t) = 0 and
Strategy D: combination of u1(t), u2(t), u3(t) while setting u4(t) = 0.
Strategy A: Using all the control variables
Fig 1A shows the effect of applying all the optimal control (u1(t), u2(t), u3(t) and u4(t)) vari-
ables on the fraction of susceptible humans; without optimal controls over 70% of the popula-
tion became infected within two years. However, when applying the controls only a small
fraction of the population remain susceptible at the end of the simulation time. The optimal
controls can be seen to result in a very small fraction of infected in the mono-infected classes
(see Fig 1B and 1C as the controls act quickly from the onset of the application. Similar behav-
ior is observed in Fig 1D, the co-infected class. The fraction of the co-infected individuals at
the onset of the optimal controls quickly reduces, reaching zero co-infection in two years.
In Fig 1E, we observed that the fraction of infected humans with PKDL with and without
optimal control were the same for about 3 months after which the fraction without control
increased rapidly reaching the peak in about two and a half years compared to the fraction
with optimal control which slightly rose and remained steady for four years seven months and
then surpassing the fraction without during this time period. These infected individuals finally
reach about 9.3%. In this same time period, the fraction without optimal control reduces to
7.9% compare those with control. This reduction is due to the fact that the fraction without
Malaria/visceral leishmaniasis co-infection
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control move quickly into the PKDL-Malaria co-infected class (see Fig 1F) after three and half
years while those with control maintain a steady number with less than 5% co-infection.
Fig 2A, 2B and 2C shows the effect of the application of the optimal control on the fraction
of the infected reservoir, mosquitoes, and sandflies; it is clear that applying the optimal con-
trols reduce the fraction of these infected populations compared to the infected fraction with-
out controls.
Fig 3 show the profiles of all the controls (u1, u2, u3 and u4) in which the optimal control is
applied at the upper bound for about three, two, one and a half and two years, respectively;
these are then reduced gradually until the end of the simulation period.
To clearly show the efficacy of the control strategies in reducing the fraction of the infected
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ðtÞ. These functions measure the proportional decrease in the number of infected indi-
viduals caused by the intervention with optimal controls of strategies. The efficacy function
depicted in Fig 4 indicates that adopting the optimal control strategies can reduce over 98% of
infected individuals. The figure further shows that the control impact is quickest in the co-
infected group with close to a 100% efficacy.
Strategy B: Using personal protection measures for humans and the
reservoirs
Strategy B, involving the use of personal protection measures for humans and the reservoirs
(i.e. u1(t), u2(t) and while setting u3(t) = u4(t) = 0) has solution profiles that are similar to the
profiles in Figs 1 and 2, except for Fig 1E and they are not shown here. In Fig 5A, we observed
that the fraction of infected humans with PKDL with and without optimal control were the
same for about 3.5 months after which the fraction without control increased rapidly reaching
the peak in about two and a half years compared to the fraction with optimal control which
also reaches the peak in two and a half years and reducing to about 9% infected individuals.
Under this scenario, it takes about four years eight months for the trajectory of the with opti-
mal control to surpass the trajectory of the without optimal control (compare Figs 1E and 5A).
The efficacy function is depicted in Fig 5B and this indicates that adopting the optimal control
strategies can reduce over 98% infected individuals with the control impact been quickest in
the co-infected group with almost 100% efficacy. Fig 5C and 5D shows the optimal control
profile which are at the upper bound for the two time-dependent controls (u1 and u2)
employed.
Strategy C: Using infected reservoir animal culling and indoor residual
spraying
The solution profiles of Strategy C (i.e. u3(t) and u4(t) with u1(t) = u2(t) = 0) are also similar to
the profiles in Figs 1 and 2, except for Fig 1E and are therefore not shown here as well. This
control strategy involves the culling of infected reservoir animals and the use of insecticides
such as DDT, pyrethroids, indoor residual spraying of human dwellings and animal shelters.
In Fig 6A, we observed that the fraction of infected humans with PKDL with and without opti-
mal control were the same for about six months after which the fraction without control
Malaria/visceral leishmaniasis co-infection
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Fig 1. Simulation results of model 3 with and without controls. (a) Fraction of the susceptible humans; (b) Fraction of infected
humans with VL; (c) Fraction of infected humans with malaria with and without controls; (d) Fraction of infected humans with
malaria and VL. (e) Fraction of infected humans with PKDL; (f) Fraction of infected humans with PKDL and malaria.
doi:10.1371/journal.pone.0171102.g001
Malaria/visceral leishmaniasis co-infection
PLOS ONE | DOI:10.1371/journal.pone.0171102 February 6, 2017 15 / 31
slightly increased more than the fraction with optimal control, the infected fraction with con-
trol eventually surpassed the infected fraction without control after two years eight months.
The PKDL infected fraction without control peaked at two years six months and then reduced
to about 8% while the infected fraction with control remained at 18% (compare Figs 1E, 5A
and 6A). This is due to the poor efficacy of the controls, the efficacy of the controls on malaria
mono-infection is about 20% in the first five months while their impact on the leishmaniasis
mono-infection and the co-infection is less than 10% in the same time period (see the efficacy
function depicted in Fig 6B); although the control eventually had an efficacy of about 98% in
Fig 2. Simulation results of model 3 with and without controls. (a) Fraction of infected reservoir; (b) Fraction of infected mosquitoes with malaria; (c)
Fraction of infected sandflies with VL.
doi:10.1371/journal.pone.0171102.g002
Malaria/visceral leishmaniasis co-infection
PLOS ONE | DOI:10.1371/journal.pone.0171102 February 6, 2017 16 / 31
Fig 3. Simulation results of the control profile of model (3). (a) Control u1(t); (b) Control u2(t); (c) Control u3(t); (d) Control u4(t).
doi:10.1371/journal.pone.0171102.g003
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the co-infection, about 94% in the malaria mono-infection and 89% in leishmaniasis mono-
infection.
The efficacy of the control on malaria mono-infection and the co-infection reached 65%
after a year eight months while leishmaniasis reached this performance level after about two
years eight months (see Fig 6B). The low efficacy in the early period of the control implementa-
tion lead to this observed poor performance of this strategy even though the controls had to be
maintained at very high levels, the control u3 was at the upper bound for about three years
seven months before been gradually reduced, while the control u4 was kept at the upper bound
throughout the simulation period. Fig 6C and 6D shows the optimal control profiles for these
time-dependent control variables.
Strategy D: Using personal protection measures and culling infected
reservoirs
In utilizing this strategy (i.e., u1(t), u2(t), u3(t) while setting u4(t) = 0), we also observed simi-
lar profile as in Figs 1 and 2, except for Fig 1E and the rest are also not shown here. Thus, we
observed in Fig 7A that it takes the PKDL fraction with optimal control four years eight
months to surpass the fraction without control. After this time period, the PKDL fraction
without optimal control reduced to about 8% while those with optimal control are at 8.8%.
To maintain these efficacy, a lot of efforts is required of the three control variables (see
Fig 4. Efficacy function of the optimal control strategies of model (3).
doi:10.1371/journal.pone.0171102.g004
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Fig 7B–7D), the control u1 is expected to be at the upper bound throughout the simulation
time period, while the control u2 is to be at the upper bound for four years six months and
the control u3 is required to be at the upper bound for only a year and two months. This
strategy has over 65% efficacy in the three controls in the less than a year of implementing
the controls. Overall, it has over 99% efficacy in all the three controls (see Fig 8).
Fig 5. Simulation results of model (3) with and without controls. (a) Fraction of infected humans with PKDL; (b) Efficacy function of the optimal control
strategies of model (3); (c) Control u1(t); (d) Control u2(t).
doi:10.1371/journal.pone.0171102.g005
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Fig 6. Simulation results of model (3) with and without controls. (a) Fraction of infected humans with PKDL; (b) Efficacy function of the optimal control
strategies of model (3); (c) Control u3(t); (d) Control u4(t).
doi:10.1371/journal.pone.0171102.g006
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6 Cost-effectiveness analysis
Next, we performed a cost-effectiveness analysis. In order to justify the costs associated with
health intervention(s) or strategy (strategies) such as treatment, screening, vaccination or edu-
cational intervention, the associated benefits are usually evaluated using cost-effectiveness
analysis [32]. In this section we will consider three approaches, the infection averted ratio
(IAR), the average cost-effectiveness ratio (ACER) and the incremental cost-effectiveness ratio
(ICER).
6.1 Infection averted ratio
The infection averted ratio (IAR) is stated as:
IAR ¼
Number of infection averted
Number of recovered
: ð13Þ
The number of infection averted above is given as the difference between the total infectious
individuals without control and the total infectious individuals with control. The strategy with
the highest ratio is the most effective. Using the parameter values in Table 3, the IAR for each
intervention strategy was determined. Fig 9 shows the IAR for the four strategies implemented
(see also Table 5). Strategy B involving the use of personal protection measures (u1(t) and u2(t)
with u3(t) = u4(t) = 0) such as the use of insecticide-treated nets, application of repellents or
insecticides to skin or to fabrics and impregnated animal collars produced the highest ratio
and was therefore the most effective. This is followed by Strategy D involving the combination
of personal protection measures (u1(t), u2(t)) and culling of infected reservoirs (u3(t)). The
next effective strategy was Strategy A which combines all for control variables (u1(t), u2(t),
u3(t) and u4(t)). Strategy C involving reservoir culling and insecticide use was the least effec-
tive, this in part was due to the low number of infection averted using this strategy (see
Table 5).
6.2 Average cost-effectiveness ratio (ACER)
Next, we considered the average cost-effectiveness ratio (ACER) which deals with a single
intervention, evaluating it against the no intervention baseline option. ACER is calculated as
ACER ¼
Total cost produced by the intervention
Total number of infection averted
: ð14Þ
Fig 10 shows that the most cost-effective strategy is Strategy A, followed by Strategy D, then
B. Strategy C is the least cost-effective (see also Table 5).
To further investigate the cost-effectiveness of the various control strategies, we evaluated
the incremental cost-effectiveness ratio (ICER).
6.3 Incremental cost-effectiveness ratio
Disease control and eradication in a community can be both labor intensity and expensive.
Thus, to determine the most cost-effective strategy to use, it is imperative to carry out a cost-
effectiveness analysis. To achieve this, the differences between the various costs and health out-
comes of implementing these different interventions are compared by calculating the incre-
mental cost-effectiveness ratio (ICER). The ICER is the additional cost per additional health
outcome and we assume that the costs of the various control interventions are directly propor-
tional to the number of controls deployed. To compare competing intervention strategies
(usually two or more) incrementally, one intervention is compared with the next-less-effective
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alternative [32]. Thus, the ICER is calculated as
ICER ¼
Difference in infection averted costs in strategies i and j
Difference in total number of infection averted in strategies i and j
: ð15Þ
The ICER numerator includes (where applicable) the differences in the costs of disease averted
or cases prevented, the costs of intervention(s), and the costs of averting productivity losses
among others. The ICER denominator on the other hand is the differences in health outcomes
which may include the total number of infections averted or the number of susceptibility cases
prevented.
To implement the ICER, we simulate the model using the various interventions strategies.
Using these simulation results, we rank the control strategies in increasing order of effective-
ness based on infection averted, we have that Strategy C averted the least number of infections,
followed by Strategy A, Strategy D, and Strategy B which averted the most number of
infections.





Fig 8. Efficacy function of the Optimal control strategies of model (3).
doi:10.1371/journal.pone.0171102.g008
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A look at Table 6, shows a cost saving of 6570.1894 for Strategy B over Strategy D, this is
obtained by comparing ICER(D) and ICER(B). The lower ICER obtained for Strategy D is an
Fig 9. IAR plots indicating the effect of the control strategies A, B, C and D.
doi:10.1371/journal.pone.0171102.g009
Table 5. Total infection averted, total cost, IAR and ACER.
Strategies Total infection averted Total Cost IAR ACER
Strategy A 19.45382 823.0011 4.591037 42.30537
Strategy B 19.69121 1489.060 4.750906 75.62057
Strategy C 11.49082 1530.597 1.661732 133.2017
Strategy D 19.66483 1315.607 4.736452 66.90149
doi:10.1371/journal.pone.0171102.t005
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indication that Strategy D strongly dominate Strategy B; this simply indicates that Strategy B is
more costly to implement compare to Strategy D. Therefore, it is best to exclude Strategy B
from the set of control strategies and alternative interventions to implement in order to pre-
serve limited resources. Therefore, Strategy B is left out and Strategy D is further compared
with Strategies A and C. Hence, we obtain the following numerical results in Table 7
Since ICER for strategies C and D are positive, their comparison shows a cost saving of
201.4181 for Strategy D over Strategy C. The lower ICER for Strategy C indicates that, Strategy
C strongly dominate Strategy D. This implies that Strategy D will be more expensive to imple-
ment compare to Strategy C; thus, strategy D is excluded from further analysis. Hence, we
obtain the following numerical computations given in Table 8 by excluding Strategy D and
comparing the two remaining strategies, that is, Strategy A with C.
Fig 10. ACER plots indicating the effect of the control strategies A, B, C and D.
doi:10.1371/journal.pone.0171102.g010
Table 6. Incremental cost-effectiveness ratio in increasing order of total infection averted.
Strategies Total infection averted Total Cost ICER
Strategy C 11.4908 1530.597 133.2019
Strategy A 19.4538 823.0011 −88.8605
Strategy D 19.6648 1315.607 334.6251
Strategy B 19.6912 1489.060 6570.1894
doi:10.1371/journal.pone.0171102.t006
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Table 8 shows a cost saving of 133.2019 for ICER(C) of Strategy C, over ICER(A) of Strategy
A. Table 8 further indicate that Strategy A (from the negative ICER value) strongly dominate
Strategy C. This simply implies that Strategy C is more costly and less effective compare to
Strategy A. Thus, we exclude strategy C from further consideration.
Repeating the entire process, we can determine the next most cost-effective strategy. Thus,
we found that Strategy D is the next cost-effective strategy after Strategy A, this is followed by
Strategy B; Strategy C is the least cost-effective strategy and should be considered for imple-
mentation with a grain of salt.
Table 7. Incremental cost-effectiveness ratio in increasing order of total infection averted.
Strategies Total infection averted Total Cost ICER
Strategy C 11.4908 1530.597 133.2019
Strategy A 19.4538 823.0011 −88.8605
Strategy D 19.6648 1315.607 334.6251
doi:10.1371/journal.pone.0171102.t007
Table 8. Incremental cost-effectiveness ratio in increasing order of total infection averted.
Strategies Total infection averted Total Cost ICER
Strategy C 11.4908 1530.597 133.2019
Strategy A 19.4538 823.0011 −88.8605
doi:10.1371/journal.pone.0171102.t008
Fig 11. The objective functional indicating the effect of the control strategies A, B, C and D.
doi:10.1371/journal.pone.0171102.g011
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From this result, it is concluded that Strategy A (combination of all control variables u1, u2,
u3 and u4) has the least ICER and therefore is more cost-effective than Strategy C. And is thus,
the most cost-effective of all the strategies for control of both the mono infections and the co-
infections. This result agrees with the results obtained in Fig 11 for the objective functional for
the various control strategies.
7 Discussion and conclusion
In this paper, we applied optimal control theory to malaria/visceral leishmaniasis co-infection
model developed in [12]. The analysis shows that the disease-free equilibrium of the model is
locally asymptotically stable whenever the associated reproduction number (R0), is less than
unity and unstable otherwise. The model also exhibits backward bifurcation, a phenomenon
where two stable equilibria coexist when the reproduction number is less than unity.
To identify the parameters with the strongest impact on the model outcome, in this case, the
reproduction number, we used the normalized forward sensitivity index (elasticity). The results
of the sensitivity analysis of the co-infection model show that the biting rates (am and al) in
both vectors have the highest sensitivity index. This is followed by the disease progression rates
(bm, bl, cm and cl) in hosts and vectors, respectively. The next strong impacting parameters are
the death rate of vectors (μvm and μvl). We also found that both the treatment rate and the death
rate of the reservoirs have high negative sensitivity indexes, an indication that both parameters
have a high impact in reducing R0. However, our results show that control strategies that target
vector and reduce contact with the vectors will be the most effective control strategy.
Thus, using these results from the sensitivity analysis, we introduced four time-dependent
control variables into the model and investigated the associated benefits of different control
strategies using cost-effectiveness analysis, so as to manage both the mono- and co-infections.
This we did, using three approaches, the infection averted ratio (IAR), the average cost-effec-
tiveness ratio (ACER) and the incremental cost-effectiveness ratio (ICER).
As expected, the control strategy utilizing all four control variables (Strategy A) is the most
efficient strategy. This is not surprising, as this strategy involves the key parameters pertaining
to vector reduction. Thus, this strategy reduces contact between humans and the two vectors
(via the use of personal protection), reduces the two vector populations through the use of
insecticide and reduces the infected reservoir population via culling. Other strategies (Strate-
gies B and D) involving contact reduction via personal protection measures and reservoir cull-
ing are equally efficient, with efficacy as high as 98%. These high-efficiency levels in these
strategies are due to an early on-start efficiency level which is as high as 65% within a year of
implementing the controls. These early on-start efficiency level is lacking in Strategy C, which
takes over a year and a half to reach the 65% efficacy level. This strategy eventually attains a
high efficacy level (about 85%). This high efficacy level is due to the use of insecticide to reduce
the vector populations which we know from our sensitivity analysis has a high negative impact
on the reproduction number.
Following this results, it is therefore not surprising to see that Strategies A, B, and D averted
the most number of infection, Strategy C performed the least (see Fig 12). This result linearly
translates to the average cost, the ICER and objective functional and we can comfortably con-
clude, using the ICER result that Strategy A is the most cost-effective strategy to implement.
This is followed by Strategy D, then B and Strategy C is the poorest and least effective strategy.
It is the most costly if we are to follow the cost obtain from the average cost and objective func-
tional (see Figs 10 and 11. Strategy C also averts the least number of infection.
In conclusion, malaria, and visceral leishmaniasis are two major parasitic diseases with tre-
mendous negative consequences on the public health care system. In this paper, we have
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presented a deterministic model of a system of ordinary differential equations which couples
the dynamics of malaria and visceral leishmaniasis co-infection. And we have studied using
optimal control theory the use of personal protection, indoor residual straying and infected
reservoir culling as effective control measures against the two co-infection epidemics. There-
fore, the following results were observed from our analysis and numerical simulations:
1. The model has a DFE that is locally asymptotically stable if R0 < 1;
2. The model also exhibit backward bifurcation, a phenomenon where two stable equilibrium
coexist when the reproduction number is less than unity;
3. The application of time-dependent controls can reduce the total number of mono- and co-
infected individuals in the population;
4. The most efficient and cost-effective control strategy is the strategy involving all the control
variables (that is, Strategy A);
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